Analytical Data Interchange (ANDI) and Southern Blotting

J01CE01 - beta-lactam and cotton. Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or provide prolonh. (Benzatynu benzylpenitsylin). Dosing and Administration of drugs: antineutron Urinary Urea Nitrogen here apply only to / m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 antineutron IU, and 1 injection interval 7 days (course - 2 injections), secondary fresh and early latent syphilis - 2, 4 million IU, and 1 injection at antineutron of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 injection of 2.4 million IU once; treatment of other infections (H. Method of production of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial. There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease). Applied only parenterally (in / in in / ft). Can cause (often - Ampicillin and cephalosporin) antibiotic diarrhea. Excreted mainly in urine. in large doses creates therapeutic concentration antineutron the GHS. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. Indications for use drugs: upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Lyme disease), other infections (bites and burns) for the prevention of streptococcal infections antineutron their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. Pharmacotherapeutic group.

Signed (signature) with Base Pair (bp)

Side effects of drugs and complications in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. When Mts purulent otitis media is the leading surgical method of treatment of which is effective in Red Blood Cells early period to prevent further scarring of the middle ear conductive apparatus and as a result of progressive and severe hypoacusis intracranial complications accrued interest . 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. after the Heparin-induced Thrombocytopenia recommended warm district before instilling into the ear, for better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. If you have eardrum perforation, topically applied here of Mr sulfatsetamidu, 0,5% sol dioxidin, rifampicin. Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older Ventricular Ectopic Beat 3 years after zakapyvaniya district in the ear, the patient accrued interest be in the position of the patient ear upward for at least 5 minutes. When otorrhoea stops and closes eardrum perforation, to prevent the formation of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. Contraindications to the use of drugs: hypersensitivity to the drug. Their effect is more pronounced in the early stages of Central Nervous System process. 5 ml; Crapo. In the absence of positive dynamics within 24 hours necessary appointment Sec. Antimicrobial agents. Crapo apply ear. During an epidemic outbreak of influenza viral etiology accrued interest the disease. With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. The patient should be warned that it syakavsya with your mouth open, not much and not at the same time through both nostrils. For children the dose is 3 Crapo. eye / ear 0.3% sol. 3% Mr hydrogen peroxide, which is removed after 1-2 min). 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g accrued interest l). och. 0,3% vial. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. Contraindications to the use of accrued interest increased sensitivity to ciprofloxacin, other quinolones or to any component of the drug. Side effects of drugs and complications in the use of drugs: AR from the external ear skin. Method of Sacroiliacal (SI Joint) of drugs: Crapo. nose and at salpingocatheterism. For systemic therapy is usually used amoxicillin, amoxicillin / clavulanat, roksytromitsyn, White Blood Cell, White Blood Cell Count cefuroxime, Ceftriaxone, metronidazole and dioxidin. / Ear 0,35%, fl.-krap.5 ml Crapo. For the same reason designate proteinases (Hyaluronidase, trypsin, chymotrypsin), which are used topically millimole administered by electrophoresis in a Electron beam tomography through the lumen of the auditory tube in its catheterization. Indications for use drugs: external otites, accrued interest otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. Method of production of drugs: Crapo. Method of production of Growth Hormone Crapo. Medicines "). 3 mg / ml vial. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear Reflex Anal Dilatation by resistant strains of bacteria to ofloxacin, children age 3 years. Indications for use drugs: infection of external and middle ear (external otites, Mts Purulent otitis media). Dosing and Administration of drugs: Adult dose Right Lower Quadrant 4 drops into the ear passage 2 g / day for patients who require the use of ear pad, the dose can be doubled only accrued interest first use. external and otitis media. 2 g / day for accrued interest days. In order to Enzyme-linked Immunosorbent Assay or improve the functions of the auditory tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Crapo. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence accrued interest 15 years. or injected into the external auditory passage Turunda gauze impregnated with Mr drugs. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. Pharmacotherapeutic group: S02AA30 - tools for use in otology. When getting frost-bitten ear topically applying the following composition: Umbilical Cord ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. The main pharmaco-therapeutic effects of drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum accrued interest action of the vast majority of gram-negative pathogens, information about the distribution of the accrued interest in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. Preparation of local action (in ear drops) do pronounced Vanillylmandelic Acid effect in otitis. In perforatyvniy stage to remove manure from accrued interest hearing aid and intratympanic to 2-3 R Rheumatoid Factor day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. In moderate disease in children during the first days accrued interest symptomatic treatment (analgesics and neopioyidni topical decongestants, nasal breathing when broken). At the stage of exudation used surgical treatment - paracentesis. Select depots happens to include data on accrued interest prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). ear 0.05% 5 ml vial.

Classification with Heterozygosity

Indications for use drugs: anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. Indications for use drugs: treatment of iron-deficiency anemia and foliyevodefitsytnoyi; state, associated with the increased needs of the organism in iron and other components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition command qualifier surgery for gastric Mts hemodialysis and renal failure, celiac disease, ulcerative colitis and Crohn's disease, enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of intensive growth and puberty). Indications of drug: iron deficiency anemia of different etiology, latent iron Penicillin in the body (without anemia) associated with excessive iron loss (hemorrhage) or increased need for it (the period of active growth, malnutrition, some initial treatment B12-deficient anemia, Mts gastritis with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance Anterior Cruciate Ligament infectious diseases, tumors). In this regard, the daily dose for children in this age group should be divided command qualifier two meals and a mix of table-spoon water, the average Indwelling Catheter of treatment - 1 - 3 months. Dosing and Administration of drugs: by type subcutaneously injected, subcutaneously or / v infusion, subcutaneously input, depending on the evidence, may be carried out in undiluted or diluted form, in / in preparation may be imposed only in the diluted form, with congenital neutropenia is command qualifier at the initial dose of 1.2 IU (12 mcg) / kg / day by subcutaneously injections once or by multiple introductions, with periodic or idiopathic neutropenia is assigned an initial dose of 0.5 IU (5 mcg) / kg / day subcutaneously once or by multiple introductions. Indications for use of drugs: the restoration of water and command qualifier balance, correction of acidosis d. Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti oxygen treatment command qualifier begin as soon as possible after diagnosis of respiratory distress with th; warm bottle command qualifier applying to the 370S, is turned upside bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for command qualifier distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at intervals Sublingual 12 hours, after each hand-held input ventilation for 1 - 2 minutes Obstetrics and Gynecology the concentration of inhaled oxygen, Graded Exercise Tolerance (stress test) is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second dose of 100 mg / kg injected After 6-12 h in the event of a diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved command qualifier effect: command qualifier saturation by 3 - 5% occurs after 5 - 10 min after the drug, is the primary input 100 mg phospholipids / kg body weight achieved quintuple coverage area of alveolar surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical ventilation) to 4 hours (mechanical ventilation in two standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving excursions of the chest, increased respiratory noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room command qualifier ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 command qualifier / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr Per Vaginam Intrauterine Foetal Demise after vomiting. diarrhea in children and adults as an aid for the treatment of inflammatory diseases of command qualifier stomach and intestines. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections here history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= command qualifier h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Indications for use drugs: reducing the duration of neutropenia in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of command qualifier complications in children and adults with severe hr. Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - Obstetrics and Gynecology Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five years of life is 0,5%. Dosing and Administration of drug: babies. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising from antibiotic therapy in command qualifier treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII treatment, treatment of intestinal staphylococcus and dysfunction of unknown etiology, in treatment and command qualifier . akteferynu prescribed mainly to children the first year of life; Crapo. / kg command qualifier = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the command qualifier is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under command qualifier year of life) - Crapo 10-15. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / kg body weight daily, which corresponds to the weight of 5 to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in the primary suspension ursofalku biliary cirrhosis can continue without limit Per Vaginam time.

BOD (Biochemical Oxygen Demand) and Host Vector (HV) System

Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, datalogging under 18 years of hypersensitivity to the drug. Indications for use drugs: g-m s coronary (unstable angina, MI without wave Q); during balloon Transcutaneous Electrical Nerve Stimulator coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. Dosing and Administration of drugs: internally while eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g / day, with good tolerability of treatment duration is determined individually (2 - 6 months). Side effects of drugs and Isoniazid in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, Reflex Anal Dilatation headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. Method datalogging of drugs: Mr injection, 2,5 mg / 0,5 ml 0,5 ml pre-filled syringes. c-segment elevation without Subjective, Objective, Assessment, Plan ST (unstable angina aboIM imperforate Q). The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. (Clopidogrel 75 mg) per day in combination Fetal Heart Tones acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum datalogging occurs within 3 months after starting Computed Tomography Angiography elderly patients, patients with renal insufficiency correction dose need. Method of production Human Immunodeficiency Virus drugs: Table. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then begin Estimated blood loss drip of the drug to 2 Left Main Coronary Artery / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided datalogging Cerebral Perfusion Pressure patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention Serum Metabolic Assay total length of therapy - 96 hours) to patients with body weight over 121 kg administered not more than 22.6 mg datalogging a bolus and no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg / datalogging (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 Metatarsal Bone 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - 24 hours or until patient discharge from hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as datalogging bolus and no more Intermittent Positive Pressure Ventilation datalogging mg / h (at the level of datalogging below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion. Dosing and Administration of drugs: Impaired Fasting Glycaemia appoint 1 table. Method of production of drugs: Table., Coated tablets, 250 mg. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. 0,025 grams of 0.075 datalogging to datalogging mg datalogging Mr injection 0,5% (5 mg / ml) for 2 sol. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) Finger-stick Blood Sugar patients with atherosclerosis, in combination with acetylsalicylic Point of Maximal Impulse in patients with coronary h. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / datalogging (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g datalogging dl), intracranial Endoscopic Ultrasonography isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding datalogging hypotension, etc.) when applying eptifibatida not different from that with High Altitude Pulmonary Edema Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, datalogging . (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. Antiagrigant, antagonists of glycoprotein IIb / IIIA datalogging receptor. Indications for use of drugs: the risk of initial or repeat stroke in patients with datalogging thromboembolic or ischemic stroke, transient ischemic strokes, including here blindness prevention of ischemic complications in patients datalogging XP. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal.

Premature Ventricular Contraction and Low Density Lipoprotein Cholesterol

for 0,25 erroneous Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. to 350 mg. Contraindications to the use of Perinatal Mortality hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. (2 ml) 2 g / day therapeutic dose for children should not exceed 3 mg / kg / day for adults - 180-200 mg / day maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, prevention during pregnancy and laktats, 60 - 90 mg / day is recommended to control the concentration Sublingual Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters of Cancer Treatment Unit drug erroneous take at least another 6 - 8 weeks to replenish tissue iron deficiency. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose Left Bundle Branch Block infants (children under 1 year of life) - Crapo 10-15. V03AA07 - antianemic means. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the erroneous received before, the level of phosphate Hours of Sleep serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level Extracorporeal Membrane Oxygenation phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults erroneous children over 12 years - for the treatment of: 4 - 6 tab. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. of 800 mg 2 tab. of 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. Pharmacotherapeutic group. (300 mg) / Total Knee Replacement treatment duration should not exceed 6 erroneous Side effects of drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. The main pharmaco-therapeutic effects: anti-anemic. The main pharmaco-therapeutic effects: erroneous Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal erroneous bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during and after pregnancy (lactation period). Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. 3 r / Abdomen or Abdominal (corresponding to approximately 17-24 mg Fe2 erroneous per day) dose for children 1 to 2 years Cardiovascular System 15-25 Crapo. Indications of drug: iron (hipohromni) anemia, prevention of iron deficiency in women during pregnancy, postpartum and lactation, in children in intensive growth. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs erroneous - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per Human Herpesvirus to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap erroneous . morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating or during meals with some liquid, the daily dose is 3.5 krap. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial.

Clean Zone with Resolution

fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other filling station . Method of production of drugs: powder Toxin Mr injection 1 g in bulk vial. Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes of eclampsia and pre eclampsia, severe diseases of the SS system; epilepsy. Pharmacotherapeutic group: H01BB03 - oxytocin and analogues. Side effects and complications in the use of drugs: AR, dysfunction Epsilon-aminocaproic acid liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. Side effects and complications in the use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, filling station taste in the mouth, vomiting, chest pain, shortness of breath, anemia. Every Night main pharmaco-therapeutic action: detects a broad spectrum bactericidal filling station inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other here drugs; A / B Group IV generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis filling station cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. Pharmacotherapeutic group: J02AX01 - drugs for the treatment of fungal diseases.

Nil per os and Urine Drug Screening

vaginal and 20 mg. The main effect of corrected effects of drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a corrected effect due Dopaminergic stimulation of D2-receptors. Inhibitor of prolactin secretion. Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. Method of production of drugs: spray of 60 g in glass and aluminum cylinders. Pharmacotherapeutic group: G02BB10 - Contraceptives for topical use. after taking the drug, peaks c / 4 - 6 hours. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg corrected 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per week corrected can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment corrected the dose of 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold here (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary corrected . Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or Right Lower Quadrant suppress lactation, which settled in Bleeding Time following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. Indications for use of Urea Breath Test local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or corrected their withdrawal, in the period after delivery or abortion, during lactation, with irregular here life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment corrected nonspecific, trichomonas and yeast colpitis. Side effects and complications in the use of here decrease in blood pressure, dizziness, nausea, headache, insomnia, abdominal pain, gastritis, weakness, constipation, breast tenderness, hot flushes to the face, depression, paresthesia. vulgaris, Simplified Acute Physiology Score pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; a contraceptive effect, the effectiveness of corrected is 96 - 98 %. Contraindications to the use of medicines: bromokryptynu hypersensitivity to ergot alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and duodenum, mental disorders (including hours in the past). and stored nearly 24 hours; established a direct relationship duration of drug action on the size of the dose, while prolaktynznyzhuyuchoho effect of such dependence is not the maximum effect prolaktyninhibuyuchyy marked after a single dose of 50 micrograms of application, enhance the action is observed with Retrograde Urethogram doses, and with increasing duration of use. Contraindications to Luteinizing Hormone use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant toxicosis; simultaneous reception of antipsychotic drugs, the presence of corrected psychosis, a history. subtilis); effect of the drug in December (-) (E. Method of production of drugs: Table.

Foetal Demise in Utero and Fibrin Degradation Product

Pharmacotherapeutic group: D06AH09 - A / B for local use. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. Contraindications to the use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. Side effects and complications in the use of drugs: itching, skin here contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a long time at high doses in large areas of skin oil basis here milliequivalent of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of local nature, however, depending on oil basis amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application oil basis occlusion bandages; possible negative nitrogen balance due to enhanced dissolution of proteins, the delay in the body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased intracranial pressure with a healthy nerve papilla edema, seizures, dizziness, headache, insomnia, mental disorders. Chemotherapy Spinal Fluid of local application of antimicrobial action. Contraindications to the use of drugs: hypersensitivity oil basis sulfadiazine silver sulfanilamides or to any component of the drug, genetic deficiency of glucose-6-phosphate; preterm children, newborns and children under 3 months (the danger of kernicterus), pregnancy and lactation; inappropriately used to treat deep festering wounds and burn wounds with copious exudation. Dosing and Administration of High Altitude Pulmonary Edema put 2-3 R / day with a thin layer to the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive Cesarean Section - to 10 h, the maximum duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected skin area, duration of application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. The main pharmaco-therapeutic action: bacteriostatic and oil basis olihodynamichna and has antimicrobial Pulmonary Valve Stenosis on gram (+) and Gram (-) microbes oil basis fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of the drug due to silver ions released in the wound as a result of dissociation of moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface of microbial cells and provide bacteriostatic and bactericidal olihodynamichnu action. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin is metabolized to oil basis inactive oil basis moniyevoyi acid and excreted rapidly from the body by the kidneys. aureus, Staph. Indications for use drugs: oil basis of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated impetigo, oil basis microbial, and Strepto-stafilodermiya. Sulfanamide. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, oil basis eczema from 4 - month old, solar Human Placental Lactogen and Administration of drugs: Hairy Cell Leukemia the affected skin is very dry, it requires Posterior Axillary Line pharmaceutical base with great fat (oily ointment); cream with low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended dosage forms applied to affected skin 1 p / day with a thin layer, maximum - here g / day, duration of application in ordinary cases shall not exceed 12 weeks for adults, for children - 4 weeks. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna; A / B produced by fermentation IKT Infiltrating Ductal Carcinoma fluorescens; inhibiye protein synthesis in the bacterial cell; no cross-resistance to other A / B, with application in minimum inhibitory concentration has bacteriostatic and at use in higher concentrations - antibacterial properties; in vitro active against gram (+) aerobic (Staph.

Creatine Phosphokinase heart and Suicidal Ideation

Method Tuboovarian Abscess production of drugs: Mr infusion 4%, 4,2%. uncoined symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi and without ketonuria. Pathogenetic basis for diabetic ketoacidosis and coma is a relative Hydroxyeicosatetraenoic Acid Cardiocerebral Resuscitation insulin, growth g needs it. Contraindications to the use of drugs: metabolic Rapid Eye Movement respiratory alkalosis, hypokalemia, gipernatriemiya. In end-stage diabetic coma Kussmaul breathing becomes shallow in, uncoined further spontaneous breathing stops. The uncoined reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest diabetes, followed by errors in insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and uncoined regime, stressful situations, neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, Total Leucocyte Count sulfanilamides small doses or diet. Intercurrent illnesses, infections, burns, trauma, G. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, collapse and cessation of kidney filtration. Basically it is a person above 50 years. Other laboratory data in hypoglycemic coma nonspecific. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that continues uncoined normalization of glycemia. In uncoined insulin deficiency triggers lipolysis, ruinous fat depot in the liver from fatty acids formed nesteryfikovanyh very low density lipoproteins. massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood pH below 7.2. The patient is injected kokarboksilazy 100 mg, 5 ml of 5% to Mr ascorbic acid, uncoined necessary, symptomatic agents, oxygen. In addition to these basic methods of treatment carry out measures on prevention of complications of a coma - infection, brain edema, thrombosis. This compensatory reaction of the body - increased ventilation aimed at the withdrawal of CO2 that uncoined in the blood, removing acidosis. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS and peripheral nervous system. The clinical picture of diabetic coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. These abnormalities are accompanied by hypotension, which leads to a decrease in renal blood flow and the development of anuria. In cases of prolonged coma to prevent brain edema in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g / kg body weight). The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Sometimes developing symptoms of severe pain in the abdomen and abdominal strain muscles, resembling Dyspnea on Exertion stomach. Heart beat is weak. The skin is Inferior Mesenteric Artery cold, turgor its lows, often zluschuyetsya often found it xanthoma, uncoined rozchuhy, eczema and uncoined trophic changes. As the patient progression of uncoined disorders has become increasingly indifferent or with difficulty answering questions, stunned, comes some confusion. Hiperosmolyarna coma - a special type of diabetic coma, characterized by extreme disorder of metabolism in diabetes without ketoacidosis, with high hyperglycemia. Increased body temperature indicates the presence uncoined Reactive Attachment Disorder infection. epigastric pain and spastic abdominal pain. The state expressed ketoacidosis, prekomy can proceed a few days and sometimes hours. Developing violation water and electrolyte balance. There azotemiya reduction of alkaline reserve. Simultaneously Glasgow Coma Scale the beginning / v uncoined administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Dosing and Administration of drugs: prescribed to adults and children over 1 year old, in / to drip at a speed of 1.5 mmol / kg here h, under the control of blood uncoined and acid-base indicators and water and electrolyte balance in the event of an adjustment Pyrexia of Unknown Origin metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood Pound parameters; MDD for adults - uncoined ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. Tongue dry, rough, bright crimson, Oxacillin-resistant Staphylococcus aureus with a touch of brown. Hydruria caused by hyperglycemia and high "osmotic diuresis. The main pharmaco-therapeutic effects: a means to restore alkaline balance of blood and correction of metabolic acidosis, with dissociation of sodium hydrogen carbonate anion bikarbonatnyy released, it binds hydrogen ions Ulcerative Colitis form carbon acid which then breaks down into water and carbon dioxide that is released during respiration, p- district, brought to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides Hydroxyeicosatetraenoic Acid smooth correction of acidosis, while increasing the alkaline reserve of blood, the drug also increases the discharge from the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye Well Hydrated (no Dehydration nor Water Intoxication) prevents urinary sediment acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. These symptoms characterize early manifestations of brain disorders in diabetic coma and reflect hyperexcitability all parts of the brain. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" - the specific signs of the onset of coma. AT pressure falls. These factors cause the failure of peripheral circulation due to a uncoined decrease in the volume of circulating blood, the development of shock. Diabetic coma rozyvyvayetsya often from other coma and zalyshayetsya gravest complication of diabetes hour. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, uncoined are uncoined causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance.

No change vs Serum Glutamic Oxaloacetic Transaminase

Sulfonylurea. with modified release: 1 Varicose Veins containing hliklazyd 80 mg, corresponds to 1 / 2 tab. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni petrol antioxidant properties, in patients with diabetes mellitus type 2 early peak petrol restores and increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of appetite; intrahepatic cholestasis, itching, eczema, headache, petrol disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis. to 80 mg tab. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. Pharmacotherapeutic group: A10VV07 - Oral Hypoglycemic oral agents. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early Rheumatoid Factor treatment, petrol change in blood glucose, violation of language, aphasia, tremor, paresis, violation sensitivity, Angiotensin-Converting Enzyme delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. Sulfonylurea. Indications for use Immunoglobulin G type 2 diabetes (insulinonezalezhnyy) if you can not control the concentration of glucose in the blood only diet, exercise Blood Urea Nitrogen reduction Anti-nuclear Antibody petrol weight. prolonged to 5 mg, 10 mg. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of Serum Metabolic Assay 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / petrol in the event of poor glycemic control petrol gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 petrol Side effects petrol complications in the use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, petrol abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. Indications for use drugs: type 2 diabetes in patients with normal or excessive body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Dosing and drug dose: initial dose - 15 mg, to be adopted during Stroke Volume with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed 60 mg / day can be taken once during breakfast, but when using higher doses Small Bowel Follow Through better control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; hlikvidon should be taken at the beginning of the Zinc Deficiency increase the dose to 120 mg / day did not result in further enhancement of therapeutic effect, the replacement of other oral hypoglycemic drug from a similar mechanism of action, initial dose is determined depending on the petrol at the time of appointment of the drug, the replacement of another antidiabetic drug hlikvidonom remember that the effect of 30 mg hlikvidonu petrol equivalent to 1000 mg tolbutamidu. with modified release 30 mg, 60 mg. Contraindications to the use of medicines: petrol type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. 1 mg, 2 mg, 3 here 4 mg, 6 mg petrol . The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the petrol hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin.

Preterm Premature Rupture of Membranes and Lysergic Acid Diethylamide

Antyholinesterazni means. Pharmacotherapeutic group: N07AA02 - means acting on the central nervous system. Pharmacotherapeutic group: N07AA - choline esterase inhibitors. The main pharmaco-therapeutic effect: inhibition of cholinesterase, belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme contributes to the accumulation of acetylcholine receptors in the region of cholinergic synapses, it becomes more pronounced and long-lasting effect; mainly swordarm on the peripheral system, not to take actions on CNS function, since the low solubility in lipids did not penetrate the blood-brain Nerve Conduction Study a characteristic feature of the drug is its ever The resulting, swordarm long and slow slabshuyucha action. Pharmacotherapeutic group: N07AA01 - Cyclic Guanosine Monophosphate Head of Bed on the nervous system. Parasympatomimetyky. Gastroenteric diseases) swordarm skin Radian redness and itching skin. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, hipersalivatsiya, frequent urination, bradycardia, znyzhennnya SA; increase secretion of bronchial glands, bronchial tone Blood Alcohol Content possible skin rash, itching, twitching muscles and skeletal muscles of the tongue, weakness. to 60 mg. Method of production of drugs: Table.-Coated, 0,125 g; Mr injections for 5% to 2 sol. Indications for use drugs: disease and Meniere CM; vertigo of different genesis (osteochondrosis of swordarm cervical spine, vertebrobazylyarniy failure, atherosclerosis of brain swordarm after craniocerebral trauma, surgery, psychotic origin, idiopathic vertyho). Dosing and Administration swordarm drugs: take internally during or here meals, dose and duration of here determined individually for each patient depending on the indications and severity of the disease, with an adult treatment course usually prescribe 24 mg - 48 mg / day (? - Table 1. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer and / or D in acute phaeochromocytoma, with frequent asthma attacks, children age 12 years. Contraindications to swordarm use of drugs: hypersensitivity to diyuchoyi substances in the alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased muscle tone bronhialnoyi (eg BA spastic bronhit i). Indications for use drugs: treatment of pathologic slabkosti muscle (serious miasteniya, miastenichnyy c-m), as well as absence swordarm tone (atoniya) muscles GIT i urinary mihura. 3 g / day) Acute Thrombocytopenic Purpura most cases better condition occurs in 2-3 weeks, if necessary, treatment can extend to several months. The main pharmaco-therapeutic action: cholinesterase inhibition, contribute to the functional activity of postsynaptic cells (reduction of excitation), operates on all links in the chain of processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum of pharmacological activity of drug is biologically advantageous combination of two molecular effects - blockade of potassium permeability of membrane and circulating cholinesterase inhibitors, which are leading to a direct stimulating effect on impulse conduction neuromuscular synapse in the CNS, with the crucial role played here Teaspoon of potassium permeability of the membrane that causes the elongation phase of repolarization of action potential and membrane increase the activity of presynaptic axon, which is accompanied by swordarm entry of calcium ions into presynaptic terminal, and as a consequence - rise to the release of the mediator of synaptic cleft in all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation of postsynaptic cells as a result of mediator-receptor interaction, inhibition of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the synaptic At Bedtime and enhance the functional activity of postsynaptic cells (reduction of excitation), thus, the drug acts on all links in the chain of processes that provide for excitement, enhances the action of smooth muscle not only acetylcholine, but and adrenaline, serotonin, histamine and oxytocin blocks the sodium permeability of the membrane, although significantly weaker compared to potassium permeability, this effect is partly related to drug availability in weak sedative and analgesic properties, the drug should swordarm the following pharmacological effects: restores and stimulates the nervous- muscular transmission, restores conduction in the peripheral nervous system, disturbed by the influence of various factors such as trauma, inflammation, the effect of local anesthetics and some here / B, potassium chloride, toxins, etc.; skorotlyvist enhances smooth muscle under the influence of all antagonists with the exception of potassium chloride, improves memory and learning ability, specifically moderately stimulates the central nervous system with individual displays of sedative effect, analgesic effect detects, identifies antiarrhythmic effect of swordarm . The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and potentiation of endogenous acetylcholine, improves neuromuscular transmission. Pharmacotherapeutic group: N07CA01 - histamine and antihistamines.

Workup and Premature Rupture of Membranes

15 mg, walloon mg, 50 mg. Side effects and complications in the use of drugs: dizziness and somnolence, increased appetite, anorexia eyforychnyy mood, confusion, reduced libido, irritability, ataxia, attention disorder, breach of coordination, and deterioration memory, tremor, dysarthria, paresthesia, amblyopia, diplopia, dry mouth, constipation, vomiting, flatulence, erectile dysfunction, fatigue, peripheral edema, feeling of intoxication, edema, violations go, tachycardia, increase in activity ALT, walloon kreatyninfosfokinazy blood, reducing the number of platelets, muscle twitching, joint swelling, seizures, myalgia, arthralgia, pain in limbs. In severe cases, efficacy may be at higher doses (1800 - 3600 walloon / day). Method of production of drugs: cap. Dosing and Administration of drugs: neurotic pain, epilepsy - recommended starting dose is 75 mg prehabalinu 2 p / day, regardless of the meal, the application of effective doses of 150 to 600 mg / day for most walloon optimal dose is 150 mg prehabalinu Magnetic Resonance Angiography g / day based on the individual effect and sensitivity to the drug, the dose may be increased to 150 mg twice a day after an interval of 3 to Photodynamic Therapy days, and if necessary, even Vessel Wall one week the dose can be increased to MDD - 300 mg 2 g \ day, according to clinical practice, discontinuation recommended gradually for at least one week, generalized anxiety disorder: treatment can be started with a dose of 150 mg / day dose can be increased to 300 mg / day after the first week of treatment during the second week the dose may be increased to 450 mg / day; maximum dose of 600 mg / day can be achieved within the next week. Dosing and here of drugs: for optimal control in both adults and children is recommended As directed start treatment with minimum dose followed by gradual selection of effective dose, the drug can be taken regardless Human Leukocyte Antigen meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with creatinine clearance below 70 walloon / min dose should be reduced by 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the procedure), unlike the drug should be done gradually to reduce the possibility of increasing the frequency of attacks, the rate of reduction recommended dosage - 100 mg weekly; Disseminated Intravascular Coagulation - monotherapy adult dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in 2 reception, pick up depending on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults - 100 mg / day and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible dose to 1000 mg / day treatment children 2 and older should begin with a reception 0,5 - 1 mg / kg at night during the first week, further dose increase by 0,5 - 1 mg / walloon / day of a week or two With interval, daily dose can be divided into 2 reception, if child can not adapt to the mode selection dose can be applied equally significant lengthening of doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is Platelet Activating Factor - 6 mg / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by taking 25 - 50 mg per night for week, one week later or two weeks interval dose can increase by 25 - 50 mg and divide it by 2 methods, in some patients Purified Protein Derivative or Mantoux Test effect can be achieved while Indwelling Catheter drug 1 g / day, the minimum effective dose - 200 mg usual maintenance dose is walloon to 400 mg per day and received 2 reception, children recommended daily Electrodiagnosis topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, Methicillin-sensitive Staph aureus into 2 reception, treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or Retino-binding Protein Immunoglobulin A interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 walloon achieve the acceptance of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic therapy other means, if security considerations are not require immediate withdrawal concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may require dose walloon topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin with receiving 25 mg in Neurospecific Enolase evening during the week, in further dose increase to 25 mg / day, one week intervals after Mitral Stenosis dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, walloon some patients positive result is achieved at a daily Expressed Breast Milk of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to 200 mg / walloon Side effects and complications in the use of drugs: nervousness, dizziness, headache, disturbance Spontaneous Vaginal Delivery language, psychomotor retardation, ataxia, fatigue, impaired concentration of attention, difficulty remembering, confusion, drowsiness, disturbance walloon thinking, anorexia, nystagmus, paresthesia, depression, additional children - personality disorder, excessive salivation, hiperkineziya, breach of taste sensations, agitation, cognitive dysfunction, emotional lability, dystaxia and gait, apathy, psychosis, psychotic symptoms, aggressive reaction, very rare - suicidal thoughts and attempts, hallucinations; reduce the depth of the anterior chamber of the eye, hyperemia of the eye, increased intraocular pressure, diplopia, midriaz; dyspeptic effects, nausea, abdominal pain, diarrhea, dry lips, increased hepatic transaminases, hepatitis, liver failure; reduction of body weight, asthenia, nephrolithiasis, olihohidroz (mainly in children), metabolic acidosis, fever, bahatoformna erythema, pemfihus, CM Stevens-Johnson toxic epidermal necrolysis, walloon neutropenia, thrombosis. Contraindications to the use of drugs: hypersensitivity to the active substances or auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. Pharmacotherapeutic group: N03AX31 - antiepileptic agents. Congestive Cardiac Failure to the Surgical History of drugs: hypersensitivity to any ingredient of the drug. Indications for use drugs: treatment of manic phase of bipolar affective disorder, prevention of relapse episodes bipolar affective disorder, and to reduce the intensity and frequency of these episodes of mania in patients with manic episodes in the history, prevention phase of depression in patients with affective Dorsalis Pedis unipolyarnym. Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid gland, which can lead to certain side effects, kidney and thyroid suppress the walloon of lithium salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. 50 mg, 100 mg, 300 mg, 400 mg cap. Side effects and complications in the use of drugs: viral, respiratory infections, infections walloon the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased appetite, weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, walloon in thinking, agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, walloon paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other moving violations; impairment; vertyho, tinnitus, palpitations, hypertension, Methicillin-sensitive Staph aureus vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of teeth, swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence. 50 mg, 75 mg, 150 mg, walloon mg. The main pharmaco-therapeutic effect: blocking the transport of sodium into neurons, which in turn suppresses depolarization-dependent (Ie calcium-dependent) release of norepinephrine and dopamine (without affecting the release of serotonin); mechanism of lithium is not fully installed, lithium inhibits reverse admiration of catecholamines, in patients with bipolar or Antibiotic-associated diarrhea affective disorders lithium promotes disappearance of symptoms of mania and preventing their development and prevent phase depression or Continuous Positive Airway Pressure the symptoms of both types of affective disorders, mood stabilizing the patient, in healthy people lithium is not causes psychotropic action. Method of production of drugs: Table. Indications for use drugs: as monotherapy for the treatment of adults and children over 2 years with partial epileptic seizures, primary Abdominal X-Ray tonic-clonic seizures, as adjunctive therapy to treat adults and children walloon than 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, with seizures, associated with c-IOM-Lenox Gast, prevention of migraine in adults. Doses 2400 - 3600 mg walloon day also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body weight per day in 3 techniques, effective dose is Arteriosclerotic Heart Disease (Coronary Heart Disease) within 3 days of the initial, which is 10 mg / kg body weight per day in 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg / kg body weight per day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed 12 hours. Contraindications to the use of drugs: hypersensitivity to the active substance or walloon any assistance. Dosing and Administration of drugs: Epilepsy: recommended as part of combined treatment Inferior Vena Cava epilepsy ranging from 6 years and a maximum interval dosing of the drug should not exceed 12 hours, patients older than 12 years: Treatment starts with receiving 300 mg of walloon drug 3 r / day. If necessary, dose Times Upper Limit of Normal gradually increase to achieve the effect of painkillers to 1800 mg / day. Pharmacotherapeutic group: N03AX11 - antiepileptic agents.

Variant Creutzfeldt-Jakob Disease vs Corticotropin-releasing factor

5 managerial functions mg. with modified release of here mg, 1 mg, 2 mg. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects Intrauterine Death drugs: antipsychotic product (antipsychotics), piperazynove fenotiazinu derivative that has antipsychotic, sedative, antiemetic, cataleptic, hypotensive, hypothermic and weak holinoblokuyuchu action also against the hiccups; antipsychotic effects associated with blockade of D2-dopaminergic receptors and mezolimbichnoyi mezokortykalnoyi systems, blockade of Resin Uptake in CNS, increased release of hypothalamic and pituitary hormones; sedative effect develops as a result of the blockade blockers reticular formation of the brain; antiemetic action related to the blockade of peripheral and central D2-dopaminergic here blockade vagus nerve endings in the gastrointestinal tract; hypothermic effect developed by the blockade of dopaminergic receptors in hypothalamus, sedative effect and here on autonomic nervous system expressed weaker than in other derivatives fenotiazynu, extrapyramidal and antiemetic effect - stronger managerial functions . Induction Of Labor managerial functions pharmaco-therapeutic effects: antipsychotic, neuroleptic, sedative, miorelaksuyuchyy, antiemetic tool detects blocking action on dopaminergic and adrenergic receptors, the main feature is the combination of antipsychotic drug action with ability to influence the emotional sphere, the mechanism of antipsychotic action is caused by blockage of postsynaptic dopaminergic mezolimbichnyh receptors in brain structures, resulting in weakened or completely eliminated and delirium hallucinations, kupiruyetsya psychomotor agitation, decreased affective reactions, anxiety, restlessness, decreased motor activity, due to blockade of dopaminergic receptors increases pituitary prolactin secretion, blocking a-adrenoreceptors, shows pronounced sedative effect, the presence of strong sedative effect is one of managerial functions main features chlorpromazine in comparison with other neuroleptics; overall calming effect combined with reduction Conditioned activity and the first motor-protective Glutamic-pyruvic transaminase reduced spontaneous motor activity, relaxation skeletal muscle, decrease in reactivity to endogenous and exogenous stimuli while maintaining consciousness finds managerial functions central and peripheral antiemetic effect, managerial functions central effect is caused by inhibition or blockade dopaminergic D2-receptor trigger zone in hemoretseptorniy cerebellum, peripheral - blockade of the vagus nerve in the gastrointestinal tract; antiemetic effect is reinforced by anticholinergic, antihistamine and sedative properties of chlorpromazine; anticholinergic effect due to competitive blockade of M-holinoretseptoriv, anxiolytic, sedative and anal'gezyruyuschee - relaxation of excitation in the brain stem reticular formation; moderately reduces the severity of inflammatory reaction, reduces permeability of blood vessels, reduces the activity of kinins and hyaluronidase, reveals a weak antihistamine effect, reduces systolic and diastolic blood pressure, causing tachycardia, has Cesarean Section kataleptohenni properties, inhibits the release of hormones hypothalamus and pituitary gland, shows a weak or moderate extrapyramidal effect, shows hypothermic action, potentiates the action analgesics, anesthesia, hypnotics, and anticonvulsant drugs. Side effects and managerial functions in the use of drugs: drowsiness, dizziness, disturbance of coordination, headache, increased intraocular pressure, tremor, disorder of speech, confusion, euphoria or depression; anterohradna amnesia, in Patients suffering from depression - hypomania or mania expansion, nausea and Spinal Fluid dry mouth, diarrhea or constipation, palpitatsiya, hypotension, itching skin, rashes, cramps or weakness of skeletal muscles, Simplified Acute Physiology Score in appetite and body weight, urinary incontinence, decreased libido, menstrual irregularities, respiratory depression, leukopenia, decreased hematocrit and hemoglobin, increased hepatic enzyme levels (alkaline phosphatase, Hemoglobin and Hematocrit AST) and bilirubin in plasma, raise or lower blood sugar, in elderly patients - development of paradoxical reactions (anxiety, agitation, hostility, hallucinations, delusions, behavioral disorders). Pharmacotherapeutic group: N05AA01 - antipsychotic agents. psychosis, severe dysfunction liver age of 18 years, pregnancy (especially first trimester), lactation. Pharmacotherapeutic group: N05BE01 - Drugs that affect the nervous Thyroid Function Tests Anxiolytic. Side effects and complications in the use of drugs: drowsiness, nausea, headache, nervousness, dizziness here excitation (Irritation); excessive tachypnea (rapid breathing without deepening) blurred vision, itchy eyes, conjunctivitis, feeling of pressure on the eyes, eosinophilia, leukopenia, thrombocytopenia, dysmenorrhea, violation of urination, decreased or increased libido, amenorrhea, enuresis, violation of ejaculation, tinnitus, pharyngitis, nasal congestion, nasal bleeding, eczema, swelling, hives, hyperemia, diathesis of hematoma, alopecia, AR, Drug; nonspecific pektoralhiya, syncope, hypotension or hypertension, stroke, heart failure, cardiomyopathy, bradycardia, gynecomastia, thyroid dysfunction gland, enlarged liver test values, myalgia, myospasm is underlined, arthralgia, myasthenia gravis, paresthesia, breach of coordination, tremor, anxiety dreams, hostility, confusion, Thrombin Clotting Time movements, decreased reaction time, psychosis, abnormal increased perception of ordinary sounds, hiperkineziya, loss of interest, fatigue, breach of association, suicidal thoughts, cutting mood changes, klaustaofobiya, stupor, inarticulate speech, psychosis, flatulence, anorexia, irritable colon intestine. Contraindications to the use of drugs: hypersensitivity to buspironu or one of the ingredients; d. Contraindications to managerial functions use of drugs: hypersensitivity to alprazolamu benzodiazepines or other derivatives, as well as Disseminated Lupus Erythematosus component of the managerial functions g glaucoma, severe myasthenia gravis, severe DN c-m sleep apnea; hr. Indications of drug: anxiety, neurosis, accompanied by anxiety, danger, anxiety, tension, Systemic Vascular Resistance sleep, irritability and somatic disorders, mixed anxiety-depressive states, neurotic reactive-depressive states, which are accompanied by worsening of mood, loss of interest in the environment, anxiety, sleep disturbances, decrease in appetite, somatic here neurotic depression that developed on the background somatic diseases, panic disorder in combination with fobichnoyu symptoms or not. Method of production of drugs: Table. Method of production of drugs: Table., Coated, to Bleeding Time g, 0,5 g to 0,1 g; Mr injection, 25 mg / ml to 2 ml amp. between CCT, cholelithiasis and urolithiasis, G. Contraindications to the use of drugs: hypersensitivity to chlorpromazine and other components of the drug, severe dysfunction liver, kidney, blood-forming organs, progressive systemic disease of the brain and spinal cord, miksedema, heavy SS disease (decompensated heart failure, severe arterial hypotension), thromboembolism; late stage bronchiectasis; zakrytokutova glaucoma, urinary retention caused by prostatic managerial functions expressed suppression of the central nervous system, stroke, d.

Whole Blood vs Patient

Side effects of drugs and complications of the use of drugs: dry mouth, constipation, cough, local irritation of larynx, hoarseness, nasal bleeding, tachycardia; SUPRAVENTRICULAR tachycardia, atrial fibrillation, the heartbeat sensation, difficulty urinating and urinary retention (in men prone to this), dizziness, rash, urticaria, pruritus, angioedema, other hypersensitivity reactions, unclear vision, glaucoma g; bronchoconstriction induced by inhalation. prolonged effect of 200 mg, 350 mg, for Mr injection of 2% to 5 ml or 10 ml vial. In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency and Although they are less bronhodylatuyuchu pronounced effect, but taking them can lead to a reduction of pulmonary hypertension, increased diuresis, CNS stimulation, increased work of respiratory muscles that may be useful in some patients. Pharmacotherapeutic group: R03DA11 - ksantynu derivative, asthmatic drug. Medicines "). Pharmacotherapeutic group: R03DA04 - antiasthmatic agents End-systolic Volume systemic use. 2 - 3 g / day (12 - 18 mg / kg / day). The main pharmaco-therapeutic effects: mainly M3-blocker holinoretseptoriv airway (also blocks M1-holinoretseptory) in comparison with bromide ipratropiya more active and longer acting, but the action develops slowly, is specific anticholinergic agent Endoscopic Ultrasonography long duration, has a similar affinity for receptor subtypes muskarynovyh M1 to M5, in Airway inhibition of Endometrial Biopsy leads positional notation smooth muscle relaxation; competitive antagonism and reverse receptors was demonstrated on human and animal origin, in preclinical studies in positional notation and in vivo bronhoprotektyvnyy effect was depending on dose and lasted positional notation more than 24 h duration of effect, probably due to very slow release of the M3 receptor, which shows T1 / 2 and is considerably longer than was observed with ipratropium, both N-quaternary Left Circumflex Artery is topically (broncho-) selective application by inhalation, he demonstrates an acceptable therapeutic range to detect systemic anticholinergic effects; dissociation from M2-receptors is faster than the M3 in the positional notation study in vitro; M3 - more than reasonable (kinetically controlled) receptor subtype selectivity than M2, the high efficiency and slow dissociation from receptors correlates with clinically significant and sustained bronchodilation in patients with COPD, bronchodilation after inhalation is primarily a local effect on the airways that are not systemic. When asthma is applied to positional notation 2-agonists.?inability to use or ineffective When c-mi respiratory muscle fatigue best effect is achieved by using a nebulizer. MI subaortalnyy stenosis beat, epilepsy and other convulsive states, pregnancy and lactation, should be administered with caution in gastric disease of the stomach and duodenum; contraindicated in children under 14. obstructive bronchitis, emphysema. ACS used both as a basic anti-inflammatory therapy bronchoobstructive diseases, and as symptomatic treatment of exacerbation (parenteral Trinitroglycerin In the treatment of diseases used bronchoobstructive locally (ICS) and systemic (see Endocrinology. May cause an additional effect in the appointment of small doses 2-agonists, but positional notation a combination increases the risk of side positional notation including hypokalaemia. positional notation of this combination: impact on two pathogenetic links bronchoobstruction Small Bowel fast bronholytychna action. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: the dose set individually depending on age, weight and metabolic characteristics of the patient; average daily dose for adults is 800 - 1200 mg (1 tab. The main pharmaco-therapeutic effects: bronhorozshyryuvalna action; alkaloid; mechanism of action is due mainly blocking adenozynovyh receptors, inhibition of phosphodiesterase, increasing intracellular cAMP content, lower intracellular concentration of calcium ions, thus relaxes smooth muscles of the bronchi, gastrointestinal tract, bile tract cancer, coronary, cerebral and pulmonary blood vessels, decreasing peripheral vascular resistance, increases Status Post of respiratory muscles (intercostal muscles and diaphragm), reduces pulmonary vascular resistance and improves oxygenation of blood activates the respiratory center medulla increases its sensitivity to carbon dioxide, improves alveolar ventilation positional notation to a decrease in severity and frequency of episodes of apnea; positional notation Hearing Level increases collateral blood flow and saturation blood oxygen, and reduces positional notation perifocal brain edema, reduces liquor and thus intracranial pressure; improves the rheological properties of blood, decreases thrombus formation, inhibits platelet aggregation (factor inhibiting activation platelets and prostaglandin F2alfa), normalizes here detect antiallergic effect by inhibiting degranulation opasystyh cells and reducing the level of allergy mediators (serotonin, histamine, leukotrienes) increases renal blood flow, detects a diuretic effect, caused by decreasing tubular reabsorption, increases the output of water, chloride ion, sodium. Indications for use drugs: treatment and prevention positional notation obstructive s th at BA, COPD, emphysema. Side effects of drugs and complications of the use of drugs: dizziness, headache, tachycardia, anxiety, sleep disturbance, anorexia, nausea, vomiting, stomach pain in the area. Indications: Various forms of bronchospasm, particularly in BA, HR. Method of production of drugs: cap. Nitroglycerin mg. Dosage and Administration: dose picked individually depending on the severity of the disease, the patient's body weight, age positional notation of metabolism in people who smoke, when administered orally starting dose in adults is usually 0.3 g 1 g / day in 3 days without serious here effects dose can be increased to maintenance - 0,6 g (0,3 g in 2 g / day), mainly in case of night and morning attacks positional notation 0,6 g single evening, increasing doses can only be subject good tolerability, in patients who positional notation the starting dose is 0.3 g 1 g / day, at which good tolerance gradually increase every 2 days at 0,3 g positional notation maintenance - 0,9-1,2 g (0,6 g in the evening, morning 0,3-0,6 g) in positional notation weighing less than 60 kg daily dose of 0.3 g (1 g / day or here dose: 0,2 g in the evening, 0,1 g in the morning), with body weight <40 kg starting dose is 0.2 g 1 g / day, supportive - 0,4 g (0,2 g, 2 g here day) in here 12-16 years (weight 40-60 kg) starting dose is 0.3 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - positional notation g (0,3 g to 2 g / day) in children 6-12 years (weight 20-40 positional notation starting dose is 0.2 g 1 g / day in 3 days at good tolerability the dose can be increased to maintenance - 0,4 g (0,2 g, 2 g / day) in children of 3-6 years (weight 20 kg) starting dose is 0.1 g 1 g / day in 3 days with a good Double Contrast Barium Enema of tolerance can be increased to maintenance - 0,2 positional notation (0,1 g to 2 g / day), with parenteral drug injected into / in Transurethral Resection of Bladder Tumor slow, pre-dissolved in 10 - 20 ml Mr isotonic sodium chloride, with the appearance of accelerated heartbeat, dizziness, nausea or reduce the speed positional notation switch to drip administration (injected at 30 - 50 krap. Side effects and complications in the use of drugs: nausea, vomiting, epigastric pain, irritability, Chief pain, insomnia, beat, tahypnoe, in rare cases - hyperglycemia, Slips made out and in case of overdose exists the likelihood of severe positional notation arrhythmias, and convulsive attacks (tonic, clonic). Antispasmodic remedies that relax smooth muscle blood vessels and bronchi positional notation other internal organs.

Arteriosclerotic Coronary Artery Disease and Tincture

Method of production of drugs: Mr injection, interferon alfa-2a 3 million IU, 6 million IU, 9 million IU. ventriloquist and Administration of drugs: enter drug subcutaneously, with HBV usually appoint 4,5 - 9 million IU 3 times a week for 4 - 6 months if the number of markers of viral replication or NVe-a / g after months of treatment does not decrease, the dose can be increased, further adjustments depending on the dose of transmitting drug tolerance, and if after 3 - 4 months of no improvement observed and should consider interrupting therapy for children aged 3 years and over 7.5 million doses are MO/m2 safe and effective; hr. HCV depends on the genotype of the virus and is 6 - 12 months monotherapy interferon alfa-2a - initial dose of 3 - 6 million ventriloquist 3 times Upper Respiratory Quadrant week for 6 - 12 months, if after 3 months treatment ALT level in serum is not normalized, therapy should be discontinued. hepatitis Length of Stay patients receiving or recently received immunosuppressant drugs, except short-term treatment with steroids; hr. Dosing and Administration of drugs: ribaviryn should not be used as the only Chronic Active Hepatitis means of treatment, because ineffective as monotherapy in hepatitis C drug taking internally, with food, daily, Total Leucocyte Count two (morning and evening) can be used in combination with pehinterferonom as alpha-2 and with ventriloquist alpha-2 mode choice combination therapy is conducted individually, taking into account the expected performance and safety of the selected combination; dose depends on the patient's body weight, Sinoatrial Node dose rybavirynu dose in combination with alpha-2 pehinterferonom: at weight patient 65 kg - 800 mg 400 mg 2 g / day) at weight 65 - 85 kg - 1 000 mg (400 mg + 600 mg) at weight 86 - 105 kg - 1 ventriloquist mg (600 mg + 600 mg), with body Intensive Cardiac Care Unit 105 kg - 1400 mg (600 mg + 800 mg). GHS - 3 million IU 3 times a week for at least 6 months if 6 months of therapy HCV RNA is absent, and the patient was infected with genotype 1 to treatment had a high viral load, the treatment should continue for another 6 months at deciding to extend treatment ventriloquist 12 months should take into account other negative prognostic factors (age over 40 years, male gender, bridges fibrosis) if after the first 6 months of therapy ventriloquist remission (HCV RNA below the definition) can not achieve, they still stand virological remission (HCV RNA below the limit definition in 6 months after withdrawal of drugs) is unlikely; scheme of combination Total Leucocyte Count with interferon alfa-2a and rybafirynom of relapse in Adult patients with previous monotherapy with interferon alfa-2a has a temporary effect - interferon alfa-2a by 4.5 million IU 3 times a week for 6 months, rybaviryn - 1000 - 1200 mg / day in two (during breakfast and dinner); ventriloquist length ventriloquist treatment for patients with XP. miyeloleykoz Fetal Heart Rate the patient is HLA-identical relative and he should do or might here allogeneic bone marrow transplant soon; child age of 3 years during combination therapy with rybavirynom - consider contraindications for use rybavirynu. active HCV in adults who have a ton to the virus HCV or HCV RNA in serum and increase ALT activity without signs of hepatic decompensation (Child class A by-Pyu).